The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order on October 13, 2015 to centralize all federal Zofran claims into a multidistrict litigation (MDL). The MDL is pending in the U.S. District Court for the District of Massachusetts, where it is proceeding under the direction of Judge F.... Read more »

A Northern California couple has filed a Zofran lawsuit against GlaxoSmithKline on behalf of their young daughter. The parents seek compensatory and punitive damages, equitable relief and other relief deemed appropriate for the injuries their child sustained as an alleged result of her mother’s use of Zofran during pregnancy. The... Read more »

A Kentucky couple has filed a Zofran lawsuit against manufacturer GlaxoSmithKline, LLC (GSK) over the death of their son. The lawsuit also names Hospira, Inc., and Pfizer, Inc., makers of the generic form of the drug, as defendants. The lawsuit was filed on September 30, 2015, in the United States... Read more »

The U.S. Food and Drug Administration has asked Pfizer to update its Zoloft safety warnings to acknowledge that some studies have linked the antidepressant to infant heart defects. There is still no concrete evidence definitively connecting the drug to birth defects, but some researchers have noted an “increased risk of... Read more »

Drug maker GlaxoSmithKline (GSK) is named defendant in a Zofran lawsuit alleging the drug carries a disproportionate risk of causing congenital birth defects when taken by pregnant women. The complaint was filed by a minor plaintiff and her parents in the United States District Court for the Northern District of... Read more »

Adding to the growing docket of Zofran birth defect lawsuits is a new complaint filed in the United States District Court for the Northern District of California by a mother who alleges that her young daughter’s heart malformations and resulting health difficulties are attributable to exposure to the anti-nausea drug... Read more »

A mother from Marion County, Illinois, has filed a Zofran heart defect lawsuit against GlaxoSmithKline LLC (GSK), the manufacturer of Zofran, the anti-emetic also known as ondansetron. The Plaintiff is the mother and natural guardian of her son, who the suit claims was born with a ventricular septal defect as a... Read more »

Morning sickness is a common, but severely debilitating, symptom of pregnancy that for some women lasts the entire gestational period. For a select unlucky few, the condition becomes so severe that constant vomiting prevents the intake of nutrition – placing the developing fetus in jeopardy. For these women, who suffer... Read more »

Manufactured by GlaxoSmithKline (GSK), the drug Zofran was first approved for use by the Food and Drug Administration (FDA) as ondansetron – an anti-nausea remedy in a class of medications known as a serotonin 5-HT3 receptor antagonists. The drug was first introduced to the market after FDA approval in January,... Read more »

An Alabama mother has filed a Zofran lawsuit against GlaxoSmithKline on behalf of her daughter. She claims the pharmaceutical giant engaged in false and misleading marketing of the drug, which caused her and her physician to believe it was safe for use by a pregnant woman. The mother was prescribed... Read more »